Get started

Stockstowatch

VST Tillers Tractors looks on track for an upward moveVST Tillers Tractors Ltd (VTTL) is promoted by the VST Group of Companies, a well-known business house in South India, in technical collaboration and joint venture with Mitsubishi Heavy Industries and Mitsubishi Corporation, Japan for the manufacture of Power Tillers and Diesel Engines. Presently, the Company is engaged in manufacturing and trading of trading of tractors, power reapers, rotary tillers, power weeders, engines spares, lubes, precision, and is the largest producer of power tillers in India. VST Tillers Tractors Ltd. (VTTL) CMP is 3381.95. The Negative aspects of the company are Declining annual net profit, declining cash from operations annual, FIIs are decreasing stake, MFs are decreasing stake. The positive aspects of the company are No debt, Zero promoter pledge. Entry can be taken after closing above 3402. Targets in the stock will be 3485 and 3621. The long-term target in the stock will be 3782 and 3934. Stop loss in the stock should be maintained at Closing below 2989. The above information is provided for educational purpose, analysis and paper trading only. Please don't treat this as a buy or sell recommendation for the stock. We do not guarantee any success in highly volatile market or otherwise. Stock market investment is subject to market risks which include global and regional risks. We will not be responsible for any Profit or loss that may occur due to any financial decision taken based on any data provided in this message.
NSE:VSTTILLERSLong
by Happy_Candles_Investment
BEML can give some brave upward moves in the coming time.BEML Ltd. is the leading manufacturer of heavy earth moving equipment in Asia and an Indian Public Sector Company under the Ministry of Defence, Govt. of India. It is a Mini Ratna Public Sector Enterprise, operating in three distinct business verticals namely Mining & Construction, Defence & Aerospace and Rail & Metro. BEML Ltd. CMP is 3091.05. The Negative aspects of the company are High Valuation (P.E. = 70.5), The company's Positive aspects are No debt, Zero promoter pledge, FIIs are increasing stake, MFs are increasing stake, Improving annual net profit and Improving cash from operations annual. Entry can be taken after closing above 3104. Targets in the stock will be 3249, 3375 and 3505. The long-term target in the stock will be 3725 and 3868. Stop loss in the stock should be maintained at Closing below 2684. The above information is provided for educational purpose, analysis and paper trading only. Please don't treat this as a buy or sell recommendation for the stock. We do not guarantee any success in highly volatile market or otherwise. Stock market investment is subject to market risks which include global and regional risks. We will not be responsible for any Profit or loss that may occur due to any financial decision taken based on any data provided in this message.
NSE:BEMLLong
by Happy_Candles_Investment
PBFintech - Mapping a script using Pivots, CPR and MoneyFlow Hey Pivster's Here, I have tried to demonstrate how you can use the money flow in the market to map the script alongside its basic price action which eventually leads us to some interesting zones in the journey which are being classified as the 'buyers' or 'sellers' zone depending upon the situation of the price and money flow statistics present at that very juncture! Moreover, due to limited time we quickly dived in to see the confluence of these zones (current stop) along with Pivot Points of multiple timeframes in a single tab which give us an additional boost to our analysis and make the trade refined apart from the standard information available in the market. NSE:POLICYBZR (MTF PIVOT CHART) - NSE:POLICYBZR (CPR TRAILS CHART) - NSE:POLICYBZR ( DAILY TF CHART ) - Thank You!
NSE:POLICYBZR
by PivotMinati
ADTN 680%+ Long-Term Trade With Risks to ConsiderADTN is approaching my buy zone between $4.79 and $5.13 near historic lows. There are four key price targets on the way up, and the highest price target gives a potential ROI of around 680% if ADTN is able to return back to previous all time highs. There are some financial risks and concerns surrounding ADTN so I recommend reading articles to better understand the situation. Entry Price: $4.79 to $5.13 Sell Targets: - $7.48 - $13.71 - $24.90 - $37.46 Stop Loss: $4.65 I do recommend a stop loss given the financial concerns for ADTN.
NASDAQ:ADTNLong
by realchartchamp
SBLK 200%+ ROI Trade Setup from Insiders in CongressNASDAQ:SBLK is gaining some attention today because Senator Tuberville has purchased $100k worth of SBLK stock, a stock that is focused on forestry and mineral shipping. Senator Tuberville sits on the Senate Committee of Forestry and Agriculture so he could have some insider knowledge here. Buy price: $23 to $24 (I think an entry at $23 is possible, but I wouldn't mind buying at $24). Sell targets: - $77.50 - Previous all time highs are around $1,100. Stop Loss: $22.50, if stopped out the re-entry price is around $16-17. For now let's see if SBLK can get to $77.50 then we can discuss the other targets.
NASDAQ:SBLKLong
by realchartchamp
LSF's Bullish Rebound and 2000%+ Long-Term Growth PotentialLSF reported strong earnings this week and had a very bullish rebound. I think LSF was a dead stock, and this week is likely to capture a lot of attention and interest. The weekly candle has broken through numerous resistance levels and there is little resistance on the way up to previous all time highs at $56. This is a 2000%+ growth potential from current price levels, but I think there could be a pullback first and a lower price entry. I would buy and hold to new all time highs for this one. I definitely recommend doing some research as well to see why there has been such a bullish week.
AMEX:LSFLong
by realchartchamp
2
SLT.N0000Forming a triangle pattern in daily chart. SLT is also protecting in 200EMA line. Disclaimer: The information and analysis provided in this publication are for educational purposes only and should not be construed as financial advice or recommendations to buy, sell, or hold any securities. The author and TradingView are not responsible for any investment decisions made based on the content presented herein. Always consult a financial professional before making any investment decisions.
CSELK:SLTL.N0000Long
by rukshan2102
Balaji Amines looking good after a long time. Balaji Amines Ltd., INDIA is an ISO 9001: 2015 certified company, specialised in manufacturing Methylamines, Ethylamines, Derivatives of Specialty Chemicals and Pharma Excipients. These have been their main products, they additionally manufacture derivatives, which are downstream products for various Pharma /Pesticide industries apart from user specific requirements. Negative aspects of the company are de-growth in revenue and profit and high PE 42.1. Positive aspects of the company are low debt, net cash flow from operating activities increasing, MFs increasing stake and Zero promoter pledge. Entry can be taken after closing above 2428. Targets in the stock will be 2493 and 2553. The long-term target in the stock will be 2588 and 2600+. Stop loss in the stock should be maintained at Closing below 2130. The above information is provided for educational purpose, analysis and paper trading only. Please don't treat this as a buy or sell recommendation for the stock. We do not guarantee any success in highly volatile market or otherwise. Stock market investment is subject to market risks which include global and regional risks. We will not be responsible for any Profit or loss that may occur due to any financial decision taken based on any data provided in this message.
NSE:BALAMINESLong
by Happy_Candles_Investment
Aptus may get a Techincal impetusAptus Value Housing Finance India Ltd is a Home Loan Company. Aptus has been formed to primarily address the housing finance needs of self-employed, belonging to Low and Middle Income Families primarily from semi urban and rural markets. Negative aspects of the company are promoter decreasing the stake and high PE 29.7 of the company. Positive aspect of the company are good quarterly growth, FIIs and MFs increasing stake in the company. Entry can be taken after closing above 351. Targets in the stock will be 360, 367 and 375. The long-term target in the stock will be 384 and 392. Stop loss in the stock should be maintained at Closing below 326 or 313 depending upon your risk taking ability. The above information is provided for educational purpose, analysis and paper trading only. Please don't treat this as a buy or sell recommendation for the stock. We do not guarantee any success in highly volatile market or otherwise. Stock market investment is subject to market risks which include global and regional risks. We will not be responsible for any Profit or loss that may occur due to any financial decision taken based on any data provided in this message.
NSE:APTUSLong
by Happy_Candles_Investment
MPW's $4.60 Price Target After Bullish BreakoutTechnical Analysis MPW has been showing some solid bullishness out of the buy zone. There has been 6 consecutive green weekly candles so far including this week. MPW is forming a bullish breakout above this light blue trendline and orange resistance zone. I think there will be a pullback at some point, but for now the trend is still bullish and $4.60 is the key price target on this move up. Medical Properties Trust (MPW): Navigating Liquidity And Strategic Asset Management Medical Properties Trust Inc. (NYSE: MPW) recently shared insights into its financial health and strategic direction during its fourth quarter 2023 earnings call. With a focus on creating significant liquidity and managing its diverse portfolio of healthcare facilities, the company outlined its plan to navigate through current challenges and capitalize on its strengths. This blog delves into the key takeaways from the earnings call, highlighting both the bullish and bearish aspects of MPW’s strategy and performance. Strategic Initiatives For Enhanced Liquidity MPW’s CEO, Edward Aldag Jr., unveiled a capital allocation strategy aimed at generating at least $2 billion in liquidity by 2024. This ambitious plan involves the sale of Australian facilities and hospitals to Prime Healthcare Services, showcasing MPW’s proactive approach to capital management. These strategic asset sales, alongside ongoing opportunities, underscore the company’s commitment to financial flexibility and growth. Addressing Challenges With Optimism Despite facing issues with Steward Health Care System’s cash collections, MPW remains optimistic. The company is actively working on re-tenanting Steward properties, reflecting confidence in its ability to manage tenant-related challenges effectively. Additionally, the improved performance of Prospect Medical Holdings adds a layer of positivity, reinforcing MPW’s diversified portfolio’s strength. A Look At The Bearish And Bullish Highlights Bearish Insights: The distressed situation with Steward has necessitated strategic re-tenanting and asset sales to ensure consistent rent payments. A significant write-down of $90 million for loans to Steward underscores the financial challenges faced. Concerns remain for an operator within the cash accounting pool, projecting no financial support due to low coverage. Bullish Perspectives: Interest from multiple potential tenants for Steward properties indicates robust demand for MPW’s assets. The company’s European and American portfolios, including Circle Health and Priory, demonstrate strong performance. Prospect Medical Holdings’ turnaround contributes to the positive outlook, highlighting potential for growth. Future Outlook And InvestingPro Insights Looking ahead, MPW is poised to achieve its strategic objectives, bolstered by a focus on sustaining community health through acute care hospitals. The company’s strategic sales and financing plans aim to navigate the complex financial landscape successfully. From an investment perspective, MPW presents a mixed bag of opportunities and challenges. According to InvestingPro data, the company boasts a market cap of $2.28 billion USD and an appealing dividend yield of 15.79%. The aggressive share buyback program and low Price / Book multiple suggest that MPW may be undervalued, offering potential for income generation and price appreciation. Conclusion Medical Properties Trust Inc. is at a pivotal point, with strategic initiatives in place to enhance liquidity and manage its portfolio effectively. While challenges remain, particularly with certain tenants, the company’s optimistic approach and strategic sales indicate a forward-looking perspective. For investors, MPW’s current valuation and dividend yield may offer attractive opportunities, especially for those focused on income generation and value investing. As MPW navigates its strategic path, its ability to adapt and capitalize on its strengths will be crucial in driving future success.
NYSE:MPWLong
by realchartchamp
NVAX Bullish Breakout After Settlement of Gavi DisputeNVAX Technical Analysis NVAX has been showing some solid bullishness since settling the Gavi dispute. NVAX is pumping out of the buy zone, and there has been a bullish breakout above the light blue resistance line. The key price target ahead is the green resistance line ($6.36), a yellow resistance zone ($8.20 to $8.46), and a red resistance line ($10.23). I have $3.54 to $3.93 as my new buy zone. I think there are likely to be more buy opportunities around there. For now the price is bullish and trending up. Novavax Reaches Settlement With Gavi, Paving The Way Forward In a significant development announced on February 22, Novavax, a key player in the COVID-19 vaccine market, has reached a settlement with Gavi, the Vaccine Alliance, resolving a contentious dispute over unfulfilled vaccine orders. This settlement marks a critical juncture for Novavax, alleviating financial uncertainties and setting the stage for future growth and collaborations. The Dispute Resolution Novavax has committed to repaying Gavi a minimum of $475 million, either in cash or through vaccine supplies, by the end of 2028. This agreement comes as a resolution to a conflict stemming from Novavax’s inability to deliver on a contract for up to 350 million doses of its COVID-19 vaccine, despite Gavi’s advance payment of $700 million in 2021 and 2022. Impact On Novavax The announcement led to a significant surge in Novavax’s stock price, which climbed by 23.2% to $4.91 following the news. This is a noteworthy rebound for the company, whose stock had previously plummeted by nearly 60% amid concerns over its operational viability. The settlement not only removes a major financial overhang but also enhances Novavax’s appeal as a business partner, according to CEO John Jacobs. Settlement Terms Under the terms of the settlement, Novavax has made an upfront payment of $75 million to Gavi, with additional payments of $80 million annually in quarterly installments scheduled through 2028. These payments can be adjusted if Gavi opts to receive vaccines instead of cash. The agreement also includes provisions for extra vaccine credits, potentially worth up to $225 million, should demand exceed the annual $80 million mark. Strategic Implications For Novavax The resolution of this dispute is pivotal for Novavax, offering a path to stabilize its financials and focus on future endeavors. CEO John Jacobs highlighted the settlement’s role in mitigating the risk of a substantial one-time payment and enabling better cash flow management. The estimated present value of the settlement ranges between $300 and $400 million, signaling a strategic financial recalibration for the company. Looking Ahead With new leadership at the helm of both Novavax and Gavi, this agreement signals a fresh start and a mutual focus on future collaborations and initiatives. Novavax is already eyeing new revenue streams, with plans to introduce a combination COVID-flu vaccine by 2026 and capitalize on a malaria vaccine developed in partnership with the Serum Institute of India. These initiatives, coupled with significant cost reductions and operational streamlining, underscore Novavax’s commitment to overcoming past challenges and seizing future opportunities. Conclusion In conclusion, the settlement between Novavax and Gavi not only resolves a major dispute but also highlights the resilience and strategic pivoting of Novavax amidst the complexities of the global vaccine landscape. As the company navigates beyond its COVID-centric phase, this development offers promising insights into its potential for innovation, growth, and partnerships in the years to come.
NASDAQ:NVAXLong
by realchartchamp
Adani Wilmar looking Oil RichAdani Wilmar Ltd. is a manufacturer of Edible Oil, Vanaspati, and Specialty Fats. The Company offers soybean oil, sesame oil, sunflower oil, cottonseed oil, groundnut oil, mustard oil, groundnut oil, and coconut oil, as well as vegetable ghee. It serves households and institutional buyers. It offers products through distributors, super stockists, brokers, and other trade associates. It exports products to The Middle East countries, South East Asian countries, Africa, Ukraine, and Ghana. Adani Wilmar Ltd CMP is 389.95. The Negative aspects of the company are High Valuation (P.E. = 597.3), Declining annual net profit, declining cash from operations annual, Promoter Holding decreasing. The positive aspects of the company are No debt, zero promoter pledge, FIIs are increasing stake, MFs are increasing stake. Entry for paper trading can be taken after closing above 396. Targets in the stock will be 412 and 423. The long-term target in the stock will be 443 and 461. Stop loss in the stock should be maintained at Closing below 335. The above information is provided for educational purpose, analysis and paper trading only. Please don't treat this as a buy or sell recommendation for the stock. We do not guarantee any success in highly volatile market or otherwise. Stock market investment is subject to market risks which include global and regional risks. We will not be responsible for any Profit or loss that may occur due to any financial decision taken based on any data provided in this message.
NSE:AWLLong
by Happy_Candles_Investment
Anupam Rasayan Rising after forming a bottom.Anupam Rasayan India Ltd. is one of the leading companies in India engaged in the custom synthesis and manufacturing of specialty chemicals. It has two distinct business segments that manufacture life science related specialty chemicals including products related to agrochemicals, personal care and pharmaceuticals, and other specialty chemicals, including specialty pigment and dyes, and polymer additives. Anupam Rasayan India Ltd CMP is 940.45. The Negative aspects of the company are High Valuation (P.E. = 69.2), FIIs are decreasing stake, High promoter pledge. The company's Positive aspects are No debt, MFs are increasing stake, improving annual net profit, improving cash from operations annual, Promoter holding increasing. Entry for paper trading can be taken after closing above 945. Targets in the stock will be 970 and 1004. The long-term target in the stock will be 1020 and 1060. Stop loss in the stock should be maintained at Closing below 878. The above information is provided for educational purpose, analysis and paper trading only. Please don't treat this as a buy or sell recommendation for the stock. We do not guarantee any success in highly volatile market or otherwise. Stock market investment is subject to market risks which include global and regional risks. We will not be responsible for any Profit or loss that may occur due to any financial decision taken based on any data provided in this message.
NSE:ANURASLong
by Happy_Candles_Investment
SPX 🗝Diversify YOUR Portfolio: EVERYONE Needs to Know❕📉Hi Traders, Investors and Speculators of Charts📈 HAVE YOU EVER CONSIDERED DIVERSIFYING YOUR PORTFOLIO? Given the high risk nature of trading, having a finger in every pie is a good idea. Stocks generally are less volatile than crypto, and index funds are a great way to gain exposure to a variety of top notch stocks. If you have ever wondered about trading stonks, today's update is for YOU. Cryptocurrencies are the largest part of our focus, but that doesn't mean we don't consider other markets such as forex, commodities and stocks. So today, let's take a look at the SPX / S&P 500. Index investing, especially in the S&P 500, streamlines stock market engagement. Investing here means tapping into America's corporate giants, offering long-term returns and simplicity, often outperforming active stock picking. Since 1957, the S&P 500 has offered a global economic snapshot, including key international corporations. Its careful selection process reflects market trends, focusing on criteria like market cap and liquidity. The top 4 stocks in the SPX by weight are : 1) Microsoft Corporation / NASDAQ:MSFT 2) Apple Inc. / $AAPLE 3) Nvidia Corp / NASDAQ:NVDA 4) Amazon.com Inc. / NASDAQ:AMZN # Company Portfolio% 1 Microsoft Corp 7.14% 2 Apple Inc. 6.36% 3 Nvidia Corp 4.24% 4 Amazon.com Inc 3.65% To put it into perspective, the last 4 stocks are: 500) NASDAQ:NWL / Newell Brands Inc. Producer Manufacturing 501) NYSE:DXC / DXC Technology Company Technology Services 502) NYSE:AAP / Advance Auto Parts Inc. Retail Trade 503) NYSE:TPR / Tapestry, Inc. Retail Trade / with a market cap of 4,017,225,400 (There are actually 503 stocks in the S&P500). From the above, we can clearly conclude that what happens in those top 4 markets, holds quite a lot more weight than the rest. This should give you a clue which ones to look at if you want to invest in additional stocks and not necessarily a fund. To correctly identify the macro phase is to have power - this will eliminate fear and greed, and cancel out the noise you hear from news and "influencers". Looking at SPX from a monthly perspective, we can clearly identify a strong bullish trend as the market loses makes what seems to be UP ONLY and keeps on making higher highs. By using the S&P 500 or the AMEX:VTI , you can more easily spot the macro trend of the stock market, and which way MOST of the stocks will go, especially the top few. If you found this content helpful, please remember to hit like and subscribe and never miss a moment in the markets. _______________________ 📢Follow us here on TradingView for daily updates📢 👍Hit like & Follow 👍 CryptoCheck SP:SPX NASDAQ:MSFT NASDAQ:AAPL NASDAQ:NVDA NASDAQ:AMZN
SP:SPXLong
by CryptoCheck-
Tata Elxsi giving encouraging signsTata Elxsi Ltd. is a global design and technology services company for product engineering and solution services across industries including Automotive, Broadcast, Communications, Healthcare, and Transportation. The operations are classified into two business divisions, i.e., Software Development and Services and Systems Integration and Support. Tata Elxsi Ltd CMP is 7776.30. The Negative aspects of the company is High Valuation (P.E. = 60.8). The positive aspects of the company are Zero promoter pledge, FIIs are increasing stake, MFs are increasing stake, improving annual net profit, Improving cash from operations annual. Entry can be taken after closing above 7858. Targets in the stock will be 8150 and 8591. The long-term target in the stock will be 8951 and 9188. Stop loss in the stock should be maintained at Closing below 7356. The above information is provided for educational purpose, analysis and paper trading only. Please don't treat this as a buy or sell recommendation for the stock. We do not guarantee any success in highly volatile market or otherwise. Stock market investment is subject to market risks which include global and regional risks. We will not be responsible for any Profit or loss that may occur due to any financial decision taken based on any data provided in this message.
NSE:TATAELXSILong
by Happy_Candles_Investment